HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuaki Isobe Selected Research

3- (3,4- dichlorobenzyl)- 5- (3,4,5- trihydroxybenzylidene)thiazolidine- 2,4- dione

7/2008The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuaki Isobe Research Topics

Disease

50Atrial Fibrillation
06/2022 - 07/2005
30Heart Failure
10/2022 - 05/2003
25Myocarditis (Carditis)
06/2021 - 07/2003
22Myocardial Infarction
07/2019 - 11/2002
21Inflammation (Inflammations)
01/2021 - 07/2003
17Cardiovascular Diseases (Cardiovascular Disease)
07/2019 - 07/2003
16Takayasu Arteritis (Arteritis, Takayasu's)
01/2021 - 05/2006
16Fibrosis (Cirrhosis)
03/2019 - 01/2006
14Atherosclerotic Plaque (Atheroma)
01/2018 - 03/2006
13Myocardial Ischemia (Ischemic Heart Diseases)
12/2019 - 11/2003
12Hyperplasia
08/2017 - 04/2003
12Tachycardia (Tachyarrhythmias)
05/2017 - 09/2004
11Thrombosis (Thrombus)
07/2019 - 07/2008
10Cardiac Arrhythmias (Arrythmia)
01/2022 - 09/2006
10Stable Angina
07/2017 - 05/2002
10Ventricular Remodeling
01/2013 - 01/2006
9Hypertension (High Blood Pressure)
01/2021 - 10/2010
8Aortic Valve Stenosis (Aortic Stenosis)
07/2022 - 01/2011
8Ventricular Tachycardia
06/2022 - 11/2002
8Ischemia
07/2019 - 08/2003
8Hypertrophy
05/2018 - 08/2006
8Acute Coronary Syndrome
11/2017 - 03/2008
8Hemorrhage
11/2017 - 01/2013
8Heart Diseases (Heart Disease)
07/2017 - 06/2006
8Infarction (Infarctions)
01/2017 - 11/2003
8Reperfusion Injury
02/2011 - 11/2003
7Neointima
02/2017 - 12/2002
6Sarcoidosis (Schaumann Disease)
06/2022 - 03/2003
6Peripheral Arterial Disease
10/2020 - 04/2015
6Atrial Flutter (Flutter, Atrial)
10/2020 - 05/2003
6Brugada Syndrome
06/2017 - 03/2003
6Disease Progression
01/2012 - 09/2002
5Stroke (Strokes)
01/2021 - 08/2013
5Chronic Renal Insufficiency
12/2019 - 12/2012
5Pathologic Constriction (Stenosis)
01/2019 - 03/2006
5Cardiomegaly (Heart Hypertrophy)
04/2017 - 08/2006
5Atrioventricular Block
01/2016 - 03/2003
4Frailty
08/2021 - 01/2018
4Rupture
01/2018 - 01/2011
4Spasm (Spasms)
06/2017 - 09/2007
4Vascular Remodeling
11/2016 - 12/2002
4Infections
10/2016 - 08/2003
4Atherosclerosis
01/2009 - 06/2003
4Vascular System Injuries
06/2008 - 04/2004
3Neoplasms (Cancer)
06/2022 - 03/2011
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 06/2004
3Arteritis
01/2021 - 01/2012
3Death (Near-Death Experience)
07/2019 - 01/2014
3Shock
11/2018 - 06/2006
3Aortic Valve Insufficiency (Aortic Regurgitation)
10/2018 - 01/2012

Drug/Important Bio-Agent (IBA)

12LipidsIBA
01/2018 - 06/2007
11Matrix Metalloproteinases (MMPs)IBA
12/2012 - 12/2002
10Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2002
10CytokinesIBA
09/2017 - 07/2003
9Brain Natriuretic Peptide (Natrecor)FDA Link
03/2022 - 09/2006
9Biomarkers (Surrogate Marker)IBA
10/2017 - 01/2010
8Pharmaceutical PreparationsIBA
06/2017 - 07/2005
8NF-kappa B (NF-kB)IBA
07/2013 - 07/2004
6Adenosine Triphosphate (ATP)IBA
01/2015 - 05/2002
5SteroidsIBA
10/2022 - 01/2012
5AnticoagulantsIBA
01/2021 - 08/2013
5omega-Chloroacetophenone (Mace)IBA
07/2019 - 06/2006
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2018 - 12/2004
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2013 - 06/2003
5Adenosine (Adenocard)FDA LinkGeneric
05/2013 - 05/2007
5TeaIBA
01/2009 - 06/2005
4C-Reactive ProteinIBA
01/2020 - 02/2012
4Insulin (Novolin)FDA Link
12/2019 - 03/2003
4SaltsIBA
05/2018 - 03/2005
4CalciumIBA
01/2018 - 01/2012
4Angiotensin IIIBA
01/2017 - 08/2006
4Transcription Factors (Transcription Factor)IBA
11/2016 - 07/2008
4Cardiac MyosinsIBA
12/2013 - 07/2003
4Telmisartan (Micardis)FDA Link
08/2012 - 05/2010
4PPAR gammaIBA
06/2011 - 06/2006
4Dinoprostone (PGE2)FDA Link
03/2011 - 01/2009
4Plasminogen Activator Inhibitor 1IBA
02/2011 - 07/2008
4Glucose (Dextrose)FDA LinkGeneric
01/2008 - 03/2003
3AlbuminsIBA
06/2022 - 04/2009
3Serum AlbuminIBA
08/2021 - 01/2019
3tocilizumab (atlizumab)FDA Link
01/2021 - 01/2018
3GlucocorticoidsIBA
01/2021 - 01/2017
3Messenger RNA (mRNA)IBA
10/2018 - 02/2016
3Angiotensin Receptor AntagonistsIBA
05/2018 - 01/2011

Therapy/Procedure

40Catheter Ablation
09/2017 - 05/2003
34Therapeutics
06/2022 - 04/2005
19Percutaneous Coronary Intervention
01/2022 - 03/2008
18Stents
07/2019 - 03/2006
12Transcatheter Aortic Valve Replacement
07/2022 - 01/2011
8Heart Transplantation (Grafting, Heart)
01/2022 - 06/2004
6Cardiac Rehabilitation
05/2022 - 01/2019
6Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
06/2017 - 06/2006
6Ligation
04/2016 - 01/2007
5Renal Dialysis (Hemodialysis)
07/2019 - 06/2014
5Catheters
05/2019 - 05/2004
4Lasers (Laser)
06/2022 - 03/2007
4Patient Readmission
10/2020 - 02/2008
4Drug Therapy (Chemotherapy)
07/2017 - 07/2005
3Cardiac Resynchronization Therapy
03/2022 - 11/2003
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2020 - 09/2005